Studies |
Trial ID |
Mechanism of action |
Clinical Phases/Study design |
Chemotherapy-induced Oral Mucositis |
NCT04317183 |
Topical chamomile oral gel may affect the prevention of chemotherapy-induced oral mucositis |
Recruiting/Phase 2 |
Diabetes Mellitus Type 2 |
NCT04233658 |
Chlorogenic acid, luteolin and AP can be improved antidiabetic effects through downregulation of gluconeogenesis. |
Phase 3 |
Pancreatic Cancer |
NCT00609310 |
The effect of AP on GLUT-1, HIF and VEGF prevents the proliferation of PC cells |
Suspended/Phase 2 |
COVID |
NCT04404218 |
The use of natural extracts such as AP to diminution inflammation in patients with SARS-COV-2 |
Recruiting/ Phase 2 |
Cardiovascular Risk (NUT) |
NCT04114916 |
Changes in the dilatation of the Humeral artery |
Completed |
Allergic Rhino Conjunctivitis |
NCT03365648 |
The use of rosmarinic acid, AP, luteolin and chrysoeriol can be prevent the release of histamine and interleukins |
Completed |